AMGEN INC.
Patent Owner
Stats
- 858 US PATENTS IN FORCE
- 102 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 858 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 41,030 Total Citation Count
- May 06, 1982 Earliest Filing
- 1,040 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0021,508 ROTATIONALLY BIASED INSERTION MECHANISM FOR A DRUG DELIVERY PUMPFeb 10, 16Jan 25, 18[A61M]
2018/0002,417 Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac DiseaseJun 14, 17Jan 04, 18[A61K, C07K]
2018/0002,733 METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINSJul 17, 17Jan 04, 18[C12P, C12N, C07K]
2017/0306,033 BI-SPECIFIC ANTI-CGRP RECEPTOR/PAC1 RECEPTOR ANTIGEN BINDING PROTEINS AND USES THEREOFSep 15, 15Oct 26, 17[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9920134 Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)Jun 30, 11Mar 20, 18[A61K, C12N, C07K]
9922429 Methods and apparati for nondestructive detection of undissolved particles in a fluidJun 27, 16Mar 20, 18[G06T, G01N]
9913900 Method of treating alvelor bone loss through the use of anti-sclerostin antibodiesApr 21, 17Mar 13, 18[A61K, C07K]
9914779 Administration of alpha4beta7 hetero-dimer-specific antibodyNov 21, 12Mar 13, 18[A61K, G01N, C07K]
9892523 Methods and apparati for nondestructive detection of undissolved particles in a fluidJun 27, 16Feb 13, 18[G06T, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0267,673 CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USEAbandonedNov 17, 16Sep 21, 17[C07D]
2017/0144,971 Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAbandonedJan 23, 17May 25, 17[C07D]
2017/0137,526 USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOFAbandonedJan 24, 17May 18, 17[C07K]
2016/0287,570 PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITORAbandonedJun 07, 16Oct 06, 16[A61K]
2016/0280,703 Heteroaryloxycarbocyclyl Compounds as PDE 10 InhibitorsAbandonedDec 22, 14Sep 29, 16[C07D]
2016/0237,147 Human Anti-NGF Neutralizing Antibodies As Selective NGF Pathway InhibitorsAbandonedJan 19, 16Aug 18, 16[C07K]
2016/0060,337 METHODS FOR TREATING PSORIASIS USING AN ANTI-IL-23 ANTIBODYAbandonedFeb 25, 14Mar 03, 16[C07K]
2016/0046,709 METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITORAbandonedSep 22, 15Feb 18, 16[A61K, C12Q, C07K]
2016/0039,945 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9AbandonedMar 12, 14Feb 11, 16[A61K, G01N, C07K]
2016/0031,983 METHODS FOR TREATING CROHN'S DISEASE USING AN ANTI-IL23 ANTIBODYAbandonedFeb 25, 14Feb 04, 16[C07K]
2016/0031,997 METHODS AND COMPOSITIONS RELATING TO ANTI-CCR7 ANTIGEN BINDING PROTEINSAbandonedMar 14, 14Feb 04, 16[C07K]
2016/0032,014 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9AbandonedMar 14, 14Feb 04, 16[C07K]
2015/0353,542 METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTUREAbandonedDec 11, 13Dec 10, 15[C07D]
2015/0322,144 Antibodies that Bind Myostatin, Compositions and MethodsAbandonedMar 19, 15Nov 12, 15[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.